Suntrust Banks’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Suntrust Banks’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-15,807	Closed	-$600K	–	1527
2016 Q1	$600K	Buy	+15,807	New	+$614K	﹤0.01%	864
2014 Q2	–	Sell	-9,545	Closed	-$397K	–	1609
2014 Q1	$397K	Buy	9,545 +2,523	+36%	+$108K	﹤0.01%	1446
2013 Q4	$260K	Buy	+7,022	New	+$252K	﹤0.01%	1579

Other funds holding PBE

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return

HBT

Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return

CAS

Cue Advisory Services Phoenix, Arizona $167M AUM 18.62% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Suntrust Banks's PBE Position: Q2 2016 in Review

Suntrust Banks sold out of Invesco Biotechnology & Genome ETF (PBE) in Q2 2016, closing a stake of 15,807 shares — an estimated $600K sold.

Suntrust Banks first reported a position in PBE in Q4 2013 and held it in 3 quarters. The position peaked at $600K in Q1 2016. 73 funds tracked by Wall St. Rank hold PBE as of Q2 2016.

Suntrust Banks reported no remaining Invesco Biotechnology & Genome ETF position as of Q2 2016 after selling out during the quarter.
Suntrust Banks sold 15,807 Invesco Biotechnology & Genome ETF shares in Q2 2016, an estimated $600K.
Suntrust Banks first reported a position in Invesco Biotechnology & Genome ETF in Q4 2013 and held it in 3 quarters.
Suntrust Banks's Invesco Biotechnology & Genome ETF position peaked at $600K in Q1 2016.
73 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2016.

Based on Suntrust Banks's 13F filing for Q2 2016, filed 2 Aug 2016.